I would log six to eight hours of sleep where I was unconscious, but I wasn't getting what is ‘actual’ sleep,” said Orsini, 48, of Seven Fields, Pennsylvania. Like an estimated 30 million Americans, ...

A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...

Dr. Thomas Gotsis DDS, DABDSM the Owner and President of Midwest Dental Sleep Medicine Institute chats with Angela about an ...

A Black woman sleeps peacefully surrounded by pills, charts, and various sleep devices. Sleep, the thing we all do each night ...

For starters you might not even snore.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal ...

For many people with sleep apnea, a CPAP machine feels like the only option—but it’s not. Today, we’re talking about a more ...

Sleep apnea patients get new alternatives to CPAP machines in 2026, including battery-free implants and oral medications with 47% symptom reduction.

The FDA approved the first-ever medication for obstructive sleep apnea in December 2024, expanding a treatment landscape that has long centered on continuous positive airway pressure machines.

Despite a net loss, Vivos Therapeutics Inc (VVOS) reports a 16% revenue increase for 2025, driven by strategic acquisitions and expanded service offerings.

Q4 2025 Earnings Call April 15, 2026 5:00 PM EDTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.

DARIEN, Ill. – The American Academy of Sleep Medicine (AASM) recently sent a letter to UnitedHealthcare, raising concerns about the payer’s use of Synapse Health for durable medical equipment (DME) ...